Benzinga - Wed, 24 Feb 2021 14:22:30 -0400
Benzinga - Thu, 04 Feb 2021 11:16:13 -0400
Benzinga - Tue, 22 Dec 2020 16:36:22 -0400
Benzinga - Wed, 09 Dec 2020 08:23:02 -0400
Benzinga - Wed, 09 Dec 2020 07:32:29 -0400
Benzinga - Tue, 08 Dec 2020 09:03:54 -0400
Benzinga - Mon, 07 Dec 2020 17:32:22 -0400
Benzinga - Mon, 07 Dec 2020 11:34:26 -0400
Benzinga - Mon, 07 Dec 2020 10:12:38 -0400
Benzinga - Mon, 07 Dec 2020 09:44:32 -0400
Benzinga - Sun, 06 Dec 2020 13:43:15 -0400
Benzinga - Sun, 06 Dec 2020 09:41:31 -0400
Benzinga - Fri, 04 Dec 2020 14:51:12 -0400
Benzinga - Fri, 04 Dec 2020 12:25:15 -0400
Benzinga - Fri, 04 Dec 2020 08:43:41 -0400
load more
Sector: Health Care.Industry: Biotechnology
Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidate are entinostat which has direct effects on both cancer cells and immune regulatory cells, and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-06
REV
Q4 2020Est.ActualSurprise
EPS
(EXPECTED)2021-03-08
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
SNDXSyndax Pharmaceuticals4.43%1.1B

Syndax Pharmaceuticals Company Questions & Answers

Q

How do I buy Syndax Pharmaceuticals (SNDX) stock?

A

You can purchase shares of Syndax Pharmaceuticals (NASDAQ: SNDX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Syndax Pharmaceuticals's (SNDX) main competitors?

A

Other companies in Syndax Pharmaceuticals’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Trillium Therapeutics (NASDAQ:TRIL) and Protagonist Therapeutics (NASDAQ:PTGX).

Q

What is the target price for Syndax Pharmaceuticals?

A

The latest price target for Syndax Pharmaceuticals (NASDAQ: SNDX) was reported by Morgan Stanley on 2020-12-07. The analyst firm set a price target for 25.00 expecting SNDX to rise to within 12 months (a possible 6.02% upside). 10 analyst firms have reported ratings in the last year.

Q

How much is Syndax Pharmaceuticals (SNDX) stock ?

A

The stock price for Syndax Pharmaceuticals (NASDAQ: SNDX) is $23.58 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Syndax Pharmaceuticals (SNDX) dividend?

A

There are no upcoming dividends for Syndax Pharmaceuticals.

Q

When is Syndax Pharmaceuticals (NASDAQ:SNDX) reporting earnings?

A
Syndax Pharmaceuticals’s Q1 earnings are confirmed after-market from now on May 6, 2021.
Q

When is the upcoming split for SNDX?

A

There is no upcoming split for Syndax Pharmaceuticals.